Recent News

• 02.05.2026 - ProPhase Labs Presentation as of 2/5/2026
• 02.03.2026 - ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative
• 02.03.2026 - ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative
• 02.02.2026 - Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd
• 02.02.2026 - Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd
• 01.26.2026 - ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture
• 01.26.2026 - ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture
• 01.22.2026 - ProPhase Labs Uplists from Pink Sheets to OTC Market
• 01.22.2026 - ProPhase Labs Uplists from Pink Sheets to OTC Market
• 01.05.2026 - ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value

Recent Filings

• 01.27.2026 - 8-K Current report
• 01.23.2026 - 8-K Current report
• 01.23.2026 - 8-K Current report
• 01.23.2026 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
• 01.09.2026 - 8-K Current report
• 01.09.2026 - 8-K Current report
• 01.02.2026 - EX-99.1 EX-99.1
• 01.02.2026 - 8-K Current report
• 12.29.2025 - 424B5 Prospectus [Rule 424(b)(5)]